Children's access to controlled medicines: policy lessons, intervention priorities, and a framework for action

Area of Science:

• Health Policy
• Global Health
• Pharmaceutical Access

Background:

• Children in low- and middle-income countries (LMICs) experience substantial challenges accessing controlled medicines.
• Existing barriers to pediatric controlled medicine access require comprehensive, policy-driven, system-level interventions.
• There is a critical need for research on effective policy strategies to address this global inequity.

Purpose of the Study:

• To review policy guidance and resources on improving access to controlled medicines for children.
• To highlight transferable policy lessons from LMICs (Uganda, India, Costa Rica).
• To propose research and intervention priorities and a framework for actionable levers.

Main Methods:

• Purposive review of relevant policy guidance and resources.
• Analysis of policy lessons from three low- and middle-income countries.
• Synthesis of literature and multidisciplinary expert input.

Main Results:

• Identified key policy lessons and actionable levers for improving access.
• Developed a functional framework outlining strategies for enhancing pediatric controlled medicine access.
• Highlighted the importance of context-specific, system-level policy interventions.

Conclusions:

• Addressing global inequities in pediatric controlled medicine access requires targeted policy and system-level approaches.
• Transferable policy lessons and expert guidance are crucial for developing effective interventions.
• The proposed framework provides actionable steps for improving appropriate access to controlled medicines for children.